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Abstract
Background: Separately, chronic alcohol ingestion and HIV-1 infection are associated with severe skeletal muscle
derangements, including atrophy and wasting, weakness, and fatigue. One prospective cohort study reported that
41% of HIV-infected patients met the criteria for alcoholism, however; few reports exist on the co-morbid effects of
these two disease processes on skeletal muscle homeostasis. Thus, we analyzed the atrophic effects of chronic
alcohol ingestion in HIV-1 transgenic rats and identified alterations to several catabolic and anabolic factors.
Findings: Relative plantaris mass, total protein content, and fiber cross-sectional area were reduced in each
experimental group compared to healthy, control-fed rats. Alcohol abuse further reduced plantaris fiber area in
HIV-1 transgenic rats. Consistent with previous reports, gene levels of myostatin and its receptor activin IIB were
not increased in HIV-1 transgenic rat muscle. However, myostatin and activin IIB were induced in healthy and HIV-1
transgenic rats fed alcohol for 12 weeks. Catabolic signaling factors such as TGFb1, TNFa, and phospho-p38/total-
p38 were increased in all groups compared to controls. There was no effect on IL-6, leukemia inhibitory factor (LIF),
cardiotrophin-1 (CT-1), or ciliary neurotrophic factor (CNTF) in control-fed, transgenic rats. However, the co-
morbidity of chronic alcohol abuse and HIV-1-related protein expression decreased expression of the two anabolic
factors, CT-1 and CNTF.
Conclusions: Consistent with previous reports, alcohol abuse accentuated skeletal muscle atrophy in an animal
model of HIV/AIDS. While some catabolic pathways known to drive alcoholic or HIV-1-associated myopathies were
also elevated in this co-morbid model (e.g., TGFb1), consistent expression patterns were not apparent. Thus, specific
alterations to signaling mechanisms such as the induction of the myostatin/activin IIB system or reductions in
growth factor signaling via CT-1- and CNTF-dependent mechanisms may play larger roles in the regulation of
muscle mass in alcoholic, HIV-1 models.
Introduction and hypotheses
Multi-organ pathologies have been well-described in a
host of systemic disease states. For example, chronic
alcoholism and HIV/AIDS infection are each associated
with liver and kidney complications, immune dysfunc-
tion, and cardio-respiratory alterations [1-5]. Unfortu-
nately, the National Institutes of Alcohol Abuse and
Alcoholism (NIAAA) confirmed that people infected
with HIV-1 are more likely to abuse alcohol at some time
during their lives [6,7] which would likely increase the
incidence of health complications in this population.
Further, these co-morbid alcoholic and HIV/AIDS
pathologies may become more clinically apparent when
considered in parallel with increased patient survival
rates due to effective antiretroviral therapy. These co-
morbid effects, which may include memory loss and
brain damage [8,9], cardiomyopathy [10,11], compro-
mised immune function [12] with increased susceptibility
to opportunistic infection [13], are often severe and asso-
ciated with lower perceived qualities of life compared to
otherwise healthy alcoholics or HIV-1 infected patients
[14]. Significant skeletal muscle derangements such as
atrophy, weakness, and dysfunction are evident in both
disease states [15-19]. However; few reports exist that
describe the co-morbid effects of chronic alcohol inges-
tion and HIV-1 on skeletal muscle biology [10,20].
In simian immunodeficiency virus (SIV)-infected Rhesus
macaques, chronic binge-drinking during the asympto-
matic phase of the disease increased viral load and skeletal
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muscle expression of inflammatory cytokines while alter-
ing nutritional intake, but did not alter rates of skeletal
muscle protein synthesis or degradation [20]. However, as
viral load increased and SIV infection progressed to more
terminal stages (SAIDS), alcohol abuse increased expres-
sion of two muscle-specific E3 ubiquitin ligases, atrogin-1
and muscle ring finger protein-1, and drove skeletal mus-
cle proteolysis [10]. These data clearly show that binge-
like alcohol abuse exacerbates HIV-associated myopathy
during the progression of the disease. Here, we extend
these critical observations by Molina and colleagues by
using a commercially available, infection- and replication-
deficient rat model of HIV-1 that develops many AIDS-
like pathologies such as systemic muscle atrophy and
weight loss, neurological abnormalities, and respiratory
and immune dysfunctions [3,15,21-23],
Interestingly, AIDS-like pathologies can be replicated
using in vivo and in vitro models without the influence
of HIV-1 viral burden [3,23-26]. For example, evidence
has implicated HIV-1-related proteins, such as gp120
and Tat, as mediators of injury even when target cells
are not directly infected with HIV-1. Specifically, we
have shown that atrophied skeletal muscles from HIV-1
transgenic rats have altered glutathione states and
increased expression of atrogin-1 and TGFb1 [15] -
metabolic and biochemical responses we have also docu-
mented in otherwise-healthy, alcoholic muscle [16,27].
Based on this previous work, the current study was
designed to identify the catabolic effects of chronic alco-
hol ingestion and its influence on viral-independent
mechanisms of HIV-associated myopathy. Accordingly,
we fed a subset of HIV-1 transgenic rats the Lieber-
DeCarli liquid diet plus alcohol for 12 weeks. We
hypothesized that long term alcohol abuse would
exacerbate skeletal muscle atrophy, drive expression of
the cell cycle regulator myostatin and its receptor activin
IIB, alter expression of several catabolic and anabolic IL-
6 family members, drive gene expression of TNFa, and
increase p38 MAPK phosphorylation [16,28-33].
Results and discussion
We have previously described plantaris atrophy in
HIV-1 transgenic rats (republished in part in Figures
1A and 1C) and now show concomitant decreases in
total protein content (Figure 1B) compared to age- and
gender-matched wild type controls [15]. These
Figure 1 Chronic alcohol ingestion exacerbates plantaris fiber area in HIV-1 transgenic rats. (A) Relative plantaris mass, (B) total protein
content, and (C) fiber area were reduced in each disease state. Myosin heavy chain isoform (MHC) content was unchanged in any group (D).
Twelve weeks of chronic alcohol ingestion further reduced plantaris fiber area in HIV-1 transgenic rats compared to control-fed transgenic rats
(C). A portion of this figure has been previously published [15]. Values are expressed as means + SEM (n = 6-7 rats/group). Significance was
accepted at p ≤ 0.05. *, compared to control-fed, otherwise-healthy rat group. #, compared to control-fed, HIV-1 transgenic rat group.
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myopathies are readily apparent in alcoholic muscle as
well (Figure 1B) and occur independent of myosin
heavy chain isoform (MHC) expression (Figure 1C).
Moreover, MHC isoform content was unchanged in
any group (Figures 1D, 2). As expected, plantaris fiber
area was further reduced in alcoholic, transgenic rats
(Figure 1C). These data confirmed earlier reports from
terminal stage SIV-infected (SAIDS) Rhesus macaques
Figure 2 Representative (immuno)histological staining in alcoholic plantaris muscles from HIV-1 transgenic rats. Measurements of fiber
area (quantified in Figure 1C) were made from hematoxylin and eosin (H&E-stained) sections. Serial sections were also processed for
immunohistochemical detection of MHC type I and/or MHC type II (IIa, IIx, and IIb) expression. Hybrid fibers - those that stain positively for both
MHC type I and any one of the three fast MHC isoforms in rat muscle - are identified by the asterisks in the HIV + EtOH panels. For
convenience, asterisks have been provided within each group to track fibers in series.
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that alcohol ingestion exacerbates skeletal muscle wast-
ing [10].
In both animal models of HIV/AIDS, the quantity and
duration of alcohol abuse, in combination with the stage
of disease progression, may have significant influence on
the development of overt skeletal muscle atrophy. For
example, in the early stages of SIV infection, binge-like
alcohol ingestion in asymptomatic Rhesus macaques did
not alter skeletal muscle protein synthesis nor degrada-
tion rates. However, alcohol did increase viral load and
drive expression of tumor necrosis factor-a in skeletal
muscle and may reflect the early establishment of a pro-
atrophy program. If we had initiated our alcohol feeding
paradigm during a similar, asymptomatic stage in the
HIV-1 transgenic rat model (e.g., less than 5 months of
age), we might have expected muscle adaptations that
reflected the alcoholic, asymptomatic, SIV-infected Rhe-
sus macaques. Our chronic alcohol feeding paradigm
was started in HIV-1 transgenic rats that already dis-
played significant myopathies [15] and support the
notion that alcohol abuse exacerbates HIV-1 associated
skeletal muscle derangements [10]. Together, these data
clearly confirm the importance of HIV-1 infected
patients to avoid binge-like or chronic alcohol abuse or
to aggressively seek treatment options to minimize the
co-morbid impact of the diseases.
Myostatin, a member of the TGFb super family and
implicated in various models of skeletal muscle atrophy,
likely influences skeletal muscle mass via cell cycle regu-
lation and alterations to myogenic stem cells [34-39].
We confirm earlier reports that myostatin is upregulated
in alcoholic muscle [36] (Figure 3A) and show compar-
able alcohol-induced increases to its receptor, activin IIB
(Figure 3B). Alterations to myostatin and activin IIB
were also evident in muscles from alcoholic, HIV-1
transgenic rats. However, neither gene product was ele-
vated in control-fed, transgenic rat muscles signifying
that chronic alcohol ingestion may be the significant
insult that drives myostatin and activin IIB expressions,
not the associated pathology of HIV-1-related proteins.
Similarly, myostatin mRNA expression levels were
unchanged in muscles from asymptomatic or SAIDS
macaques [10] and support the notion that neither viral
infection nor HIV-1-related protein expression impact
myostatin signaling. However, this contention is contro-
versial as elevated serum and intramuscular levels of
myostatin appeared to play a role in AIDS-associated
wasting in HIV-infected men [40]. These discrepancies
in myostatin expression levels may be due in part to
variations between models (i.e., murine, simian, and
human), disease stage and progression, or nutritional
and metabolic abnormalities. More work is required to
Figure 3 Gene levels of TGFb super family members are
differentially regulated in diseased plantaris muscles. Gene
expression of myostatin (A) and its receptor activin IIB (B) were up-
regulated in alcoholic plantaris muscles regardless of HIV-1-related
protein expression. In contrast, TGFb1 was up-regulated in each
disease state (C). Unlike myostatin and activin IIB, TGFb1 gene levels
were higher in the co-morbid model compared to plantaris muscles
from control-fed, HIV-1 transgenic rats. Data are represented as
means ± range of potential values based on the 2-ΔΔCT method
[15,16] and expressed as fold changes relative to controls (n = 6-7
rats/group). Significance was accepted at p ≤ 0.05. *, compared to
control-fed, otherwise-healthy rat group. #, compared to control-fed,
HIV-1 transgenic rat group.
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clarify the involvement of myostatin signaling in HIV-1
associated myopathies.
We also confirmed earlier reports that both alcohol
abuse and HIV-1-related protein expression induce
TGFb1 gene expression [15,27], an effect that was
further increased in the co-morbid condition (Figure
3C). Predictably, the catabolic influences of chronic
alcohol ingestion and HIV-1-related protein expression
impact TGFb super family members in various degrees.
Although speculative, treatment options that affect a
broad range of factors in skeletal muscle (e.g., anti-oxi-
dant therapy or strength training paradigms) may prove
most beneficial to maintain skeletal muscle mass.
The IL-6 family of cytokines, including IL-6, LIF, CNTF,
and CT-1, regulates skeletal muscle mass [16,28,29,41].
We have previously shown [16] and confirmed here (Fig-
ure 4A) that long term alcohol abuse drives gene
expression of IL-6, an inflammatory cytokine associated
with skeletal muscle catabolism. Similarly, twelve weeks of
alcohol abuse drove expression of LIF (Figure 4B), a cyto-
kine implicated in muscle regeneration and myoblast pro-
liferation [30,42], and may reflect an early protective
response to alcohol-induced myopathy [16]. Interestingly,
this alcohol-induced expression pattern was not evident in
muscles alcohol-fed, HIV-1 transgenic rats (Figures 4A
and 4B) suggesting that different inflammatory cytokines
may play larger roles in HIV-1 myopathies. In support of
this notion, we (Figure 5A) and others [20] have reported
increased TNFa mRNA expression muscle levels of in
muscles from alcoholic, HIV-1 models. Together, these
data strongly suggest that the myotoxic effects of chronic
alcohol ingestion may manifest via multiple signaling
mechanisms that ultimately depend on the underlying
health status of the abuser.
Figure 4 Gene levels of IL-6 super family members are differentially regulated in diseased plantaris muscles. As previously described
[16], chronic alcohol ingestion induced expression of IL-6 (A) and LIF (B). The co-morbidity of twelve weeks of daily alcohol ingestion and HIV-1-
related protein expression reduced gene expression of CT-1 (C) and CNTF (D). Data are represented as means ± range of potential values based
on the 2-ΔΔCT method [15,16] and expressed as fold changes relative to controls (n = 6-7 rats/group). Significance was accepted at p ≤ 0.05. *,
compared to control-fed, otherwise-healthy rats. #, compared to control-fed, HIV-1 transgenic rats.
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The co-morbidity of chronic alcohol ingestion and
HIV-1-related protein expression reduced two anabolic
IL-6 family members, CNTF and CT-1 (Figures 4C and
4D), which may be partially responsible for reduced
plantaris mass, protein content, and fiber area (Figure
1). In support of this notion, suppressed levels of other
anabolic growth factors such as IGF-1 have been pre-
viously described in co-morbid models [10]. Interest-
ingly, protein synthesis rates were unchanged in
alcoholic, asymptomatic or SAIDS macaques [10,20]
which may suggest negligible effects stemming from
reduced growth factor levels. However, Molina and col-
leagues [10] noted that these apparent discrepancies
between reduced anabolic growth factor levels and the
well-established negative effects of alcohol abuse on ske-
letal muscle protein synthesis rates [43,44] may be due
in large part to variations in alcohol feeding paradigms
and circulating alcohol concentrations, or in sample col-
lection times during the post-absorptive state.
p38 MAPK is a stress-activated protein kinase impli-
cated in skeletal muscle catabolism [45]. Interestingly,
p38 MAPK phosphorylation and subsequent pathway
activation may be the result of oxidative stress or TNFa
induction - two upstream factors that we and others
have shown to be elevated in alcoholic and/or HIV-1
myopathies [15,16,20,46]. Here, the phospho-p38/total-
p38 ratio, an index of p38 activation, was elevated in
each disease state (Figure 5B) suggesting that this pro-
tein kinase plays a central role in these myopathies.
Moreover, TNFa-stimulated p38 activation has been
associated with downstream induction of atrogin-1
expression in in vitro models of muscle atrophy [33].
Atrogin-1, an E3 ubiquitin ligase, is increased in alco-
holic muscle [16,27,47] or muscle from HIV-1 trans-
genic rats [15]. Together, these data may describe a
TNFa/p38/atrogin-1 signaling pathway in alcoholic,
HIV-1 myopathies.
Conclusions
We have shown that chronic alcohol ingestion in HIV-1
transgenic rats increases skeletal muscle atrophy with
concomitant losses to total protein content and relative
muscle mass. These adaptations may be due in part to
increased myostatin signaling, increased catabolic cyto-
kine levels such as IL-6, TGFb1, and TNFa, altered p38
pathway activity, and decreased expression of growth
factors such as CNTF and CT-1. Importantly, we have
previously shown that certain catabolic factors such as
atrogin-1 and TGFb1 as well as anabolic factors such as
CNTF and CT-1 are redox-sensitive and can be modu-
lated with glutathione restoration strategies in alcoholic
muscle [16]. Interestingly, chronic alcohol feeding and a
mouse model of AIDS infection (MAIDS) independently
attenuated antioxidant defense capability in the liver,
and in combination, led to an additive inhibition of glu-
tathione [48]. Assuming an additive biochemical and
pathological response to alcohol and HIV-1 exists in
skeletal muscles, these data would strongly suggest that
robust, anti-oxidant therapy with glutathione precursors
such as procysteine, S-adenosyl methionine, or N-acetyl
cysteine would impact an array of catabolic and anabolic
factors and improve diseased skeletal muscle mass.




Male, Fischer 344/NHsd HIV-1 transgenic rats (hemizy-
gous NL4-3Δ gag/pol) [3] and wild type Fischer 344/
NHsd rats (~400 g) were purchased from Harlan (India-
napolis, Indiana) and housed in pairs under a 12:12
Figure 5 TNFa mRNA levels and phosphorylated p38 are
elevated in diseased plantaris muscles. (A) HIV-1-related protein
expression increased TNFa mRNA levels. Likewise, twelve weeks of
chronic alcohol ingestion increased TNFa levels in otherwise
healthy and in HIV-1 transgenic rat plantaris muscles. (B) Twelve
weeks of chronic alcohol abuse increased the ratio of phospho-p38/
total-p38 in each disease and co-morbid state. Chronic alcohol
abuse further increased this ratio in HIV-1 transgenic rat muscle.
Total p38 was unchanged in any group (data not shown).
Significance was accepted at p ≤ 0.05. *, compared to control-fed,
otherwise-healthy rats. #, compared to control-fed, HIV-1 transgenic
rat group.
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light-dark cycle. Animals were randomized into one of
four groups (n = 6-7/group): (1) wild type rats fed con-
trol diet, (2) HIV-1 transgenic rats fed control diet, (3)
wild type rats fed an ethanol-containing diet, and (4)
HIV-1 transgenic rats fed an ethanol-containing diet.
Rats were fed the Lieber-DeCarli liquid diet (Research
Diets, New Brunswick, New Jersey) containing either
alcohol or an isocaloric substitution with Maltin-Dextrin
(control diet) for 12 wk [16,27]. To acclimatize the rats
to the Lieber-DeCarli diet, alcohol was gradually added
as 18% of total calories for 1 wk, then 27% of total cal-
ories for 1 wk, and then finally 36% of total calories for
12 wk, respectively. At the end of the 12 wk, rats were
anesthetized with intraperitoneal injections of sodium
pentobarbital (50 mg/kg). Muscles were removed and
trimmed free of connective tissues, blotted dry, weighed,
and mounted in OCT for histochemical analyses or
flash frozen in liquid nitrogen for other analyses as
described below. Animals were sacrificed by removal of
the diaphragm muscle. All procedures were approved by
Atlanta Veteran Affairs Medical Center Institutional
Animal Care and Use Committee.
Plantaris morphology & myosin heavy chain (MHC)
isoform expression
Fresh plantaris muscles were embedded in OCT and
immediately frozen in isopentane cooled in liquid nitro-
gen as previously described [15]. Serial sections from
the mid-belly of the plantaris were cut at 14 or 8 μm
for analyses of CSA or MHC isoform determination,
respectively. All incubations were performed at room
temperature. For CSA determination, plantaris sections
were adhered to superfrost slides, processed for hema-
toxylin and eosin staining, dehydrated, and mounted.
For MHC isoform determination, sections were pro-
cessed for immunohistochemical detection of slow or
fast MHC protein expression using the ABC method
(Vector Labs, Burlingame, California). Sections were
rehydrated in phosphate buffered saline (PBS, pH 7.4),
incubated in blocking solution for 20 min, and then
incubated in anti-slow MHC or anti-fast MHC IgG
(Sigma, St. Louis, Missouri) for 90 min. Sections were
washed in PBS, incubated in biotinylated secondary anti-
body for 60 min, washed again in PBS, and then incu-
bated in an avidin-rich solution for 60 min. After a final
wash, positive biotin-avidin binding was observed with
diaminobenzidine. All sections were visualized with a
Leica microscope and measured using ImageJ software
(NIH, Bethesda, Maryland). Approximately 125 fibers
per muscle were analyzed.
Total muscle protein determination
Total muscle protein was determined from plantaris
homogenates using previously described methods [49].
Briefly, frozen plantaris muscles were weighed, minced,
and homogenized on ice using an electric tissue grinder
in 40 volumes of buffer that contained: 50 mM Tris, pH
7.5, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycho-
late, 1% Nonidet P-40, 1 mM PMSF, and Complete,
mini protease cocktail tablets from Roche (Indianapolis,
IN). Protein concentrations were determined by using
the Bio-Rad DC kit according to manufacturer’s instruc-
tions. Total protein per plantaris muscle was expressed
as the product of protein concentration and initial wet
weight. Aliquots of these plantaris homogenates were
processed for protein analyses via Western blot.
Western blot analyses
Equal amounts of protein were boiled for 2 minutes in
sample buffer that contained: 0.5 M Tris-HCl (pH 6.8),
10% (v/v) glycerol, 10% (w/v) SDS, 5% (v/v) b-mercap-
toethanol, and 0.05% (w/v) bromophenol blue. Samples
were separated by SDS-PAGE and transferred onto
nitrocellulose membranes using a trans-blot SD semi-
dry transfer cell (Biorad, Hercules, CA) according to
manufacturer’s instructions. All incubations were per-
formed at room temperature unless otherwise noted.
Membranes were blocked in 5% BSA diluted in TTBS
(0.01% (w/v) Tween-20) for 1 h and then incubated in
primary antibodies against phospho-p38 and total p38
(each at 1:1000 in blocking buffer, Cell Signaling Tech-
nology, Beverly, MA) overnight at 4°C. Blots were
washed in TTBS, incubated in anti-rabbit-HRP IgG
(1;2500 in blocking buffer) for 1 h, washed again and
then developed with enhanced chemiluminescent plus
western blotting detection system (GE Healthcare, Pis-
cataway, NJ). Densitometry was performed using a Che-
midoc XRS system and analyzed with Quantity One
software (Biorad, Hercules, CA). Pathway activities are
expressed as the ratios of phosphorylated protein to
total protein.
Gene expression analyses
Plantaris muscles were collected, immediately frozen in
liquid nitrogen, and stored at -80°C until processed for
real time PCR analyses as previously described
[15,16,27]. Frozen plantaris muscles were thawed and
homogenized in Trizol (1 ml/100 mg tissue) using an
electric tissue homogenizer. Total RNA (2.5 μg) was
reverse transcribed in a 40 μl final reaction volume
using random primers and M-MLV reverse transcriptase
according to manufacturer’s instructions (Invitrogen,
Carlsbad, California).
Real time PCR products were analyzed using the iCy-
cler iQ system (Bio-Rad, Hercules, California). cDNA
(10 μl of a 1:10 dilution) was amplified in a 35 μl reac-
tion containing 400 nm gene-specific primer pair and
iQ Sybr Green Supermix (Bio-Rad, Hercules, California).
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Primer sequences for LIF, CNTF, CT-1, IL-6, and
TGFb1 have been previously described [15,16,27]. Pri-
mer sequences for myostatin, activin IIB, and TNFa
were as follows: myostatin, 5’-TAACCTTCCCAGGAC-
CAGGA-3’ and 5’-GCAATAATCCAGTCCCATCC-3’;
activin IIB, 5’- CGACTTTGTGGCTGTGAAGA-3’ and
5’-TCGTTCCACGTGTGATGATGTT-3’; TNFa, 5’-
TGGCCCAGACCCTCACACTC-3’ and 5’-CTCCTGG
TATGAAATGGCAAATC-3’. Samples were incubated
at 95°C for 15 min, followed by 40 cycles of denaturation,
annealing and extension at 95°C, 60°C, and 72°C, respec-
tively. As a control, real time PCR was also performed on
2 μl of each RNA sample to confirm absence of contami-
nating genomic DNA. All reactions were performed in
triplicate and the starting quantities of the genes of inter-
est were normalized to 18S rRNA (primers supplied by
Ambion, Austin, Texas). The 2-ΔΔCT method was used to
analyze alterations in gene expression and values were
expressed as fold changes relative to control [15,16,27].
Statistics
One-way analyses of variance were performed followed
by Student-Newman-Keuls post-hoc tests using Sigma-
Stat v2.0 software. Significance was accepted at p ≤ 0.05.
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